NCT05154396 2021-12-13Neratinib Dose Escalation Regimen for HER2 Positive Early Breast CancerChineseAMSPhase 2 Unknown60 enrolled
NCT03933319 2020-07-08Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast CancerChineseAMSPhase 2 Unknown30 enrolled